Navigation Links
IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
Date:9/14/2010

OXNARD, Calif., Sept. 14 /PRNewswire/ -- The launch of IntriMed Technologies and the opening of IntriMed's first state-of-the-industry Innovation Center in Oxnard, Calif. were announced today by IntriPlex Technologies, a global leader in the design and manufacture of ultra-precise components for the data storage and healthcare industries. Founded on a 23 year heritage of engineering innovation, IntriMed (www.intrimed.com) focuses exclusively on delivering outsourcing solutions to the medical device manufacturing industry, and delivers on three value pillars - ongoing innovation, deep collaboration, and engineering and operational excellence.

As with any industry, the medical device industry continues to evolve and adapt to ever-changing market dynamics. Faced with healthcare reform, a new medical device tax, rapid technology advancement and more stringent U.S. Food and Drug Administration (FDA) oversight, original equipment manufacturers (OEMs) are increasingly looking towards strategic, long-term outsourcing partnerships as a means to temper these changes and achieve their revenue, cost and competitive objectives more rapidly.

Leveraging design innovation and manufacturing excellence that has resulted in 44 product and process patents and over 9 billion precision components, IntriMed is well-positioned to help medical device OEMs address these challenges. IntriMed provides deep engineering expertise to support product development from initial concept through volume production and assembly, and taps into OEM objectives to create highly-specialized design and process solutions that result in reduced costs, faster times to market, decreased failure rates and competitive differentiation.

IntriMed's new Innovation Center will support the company's full range of services, including product design and development, rapid prototyping, advanced tooling, precision manufacturing, secondary processing and cleaning, custom metrology and final assembly.

"Medical device manufacturers are adjusting to a 'new normal' of doing more with less," said Larry J. Czapla, IntriMed's president, "but for us this is pretty familiar ground. We've managed to help manufacturers in the disk drive industry save millions of dollars and stay ahead of a huge technology curve by laying the foundation for manufacturing success early on. From the outset, we work closely with the development team to create a tailored approach to design and manufacturing, and to help them achieve new levels of quality, technology and cost-effectiveness."

IntriMed's team of executives holds extensive leadership experience at the world's top medical device companies. The executive team includes Larry J. Czapla, President; Lawney Falloon, Chief Executive Officer; Damon Brink, Ph.D., Chief Technology Officer and Vice President, Engineering; Larry Ellis, Chief Financial Officer; Andrew Lux, Ph.D., Senior Vice President, Operations and Manufacturing; and Howard R. Baker, Vice President, Business Development and Commercial Operations.

For more information about IntriMed Technologies, please visit www.intrimed.com.

About IntriMed TechnologiesIntriMed Technologies designs, manufactures and assembles ultra-precision mechanical components critical to medical device functionality. We draw on more than 23 years of experience helping manufacturers do more with less – providing innovative product and process design, meticulous quality systems, and highly scalable, fully compliant manufacturing capabilities. The result is truly differentiated medical devices produced more cost effectively.

Think "embedded engineering": leveraging our considerable resources so our customers can better focus theirs. To learn more, visit intrimed.com.Media Contact: Priya DuaPorter Novelli Life SciencesPriya.Dua@porternovelli.com323-762-2407
'/>"/>

SOURCE IntriMed Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... The American Academy of Thermology (AAT) has announced that for the ... Qualification Course for Technicians via a two part webinar on July 30 and August ... of hardware, software, and camera setup/operations, aligns with the in-person member qualification course that ...
(Date:2/9/2016)... This market research report on the global ... of the market in terms of revenue (USD Million). ... the manufacture of microbiology culture media and related products. ... snapshot providing the overall information of various market segments ... also provides the overall information and data analysis of ...
(Date:2/9/2016)... DelveInsight,s, "Protein-Tyrosine Phosphatase ... in depth insights on the pipeline drugs ... Phosphatase 1B (PTP1B) Inhibitors. The DelveInsight,s Report ... of development including Discovery, Pre-clinical, IND, Phase ... Report covers the product clinical trials information ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/25/2016)... Software, the world-leading supplier of image data management solutions ... data management solution OMERO Plus for the newly established ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... analysis measures the characteristics and behavior of cells, tissues ... as health and disease, the presence or absence of ...
Breaking Biology News(10 mins):